These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2900221)

  • 21. Opioid hypofunction in Parkinson's disease.
    Sandyk R; Gillman MA
    Med Hypotheses; 1985 Feb; 16(2):179-82. PubMed ID: 2581117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurochemical mechanism of the central control of feeding].
    Jiang LH; Shen E
    Sheng Li Ke Xue Jin Zhan; 1984 Apr; 15(2):120-5. PubMed ID: 6149617
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of serotonin- and dopaminergic systems of the brain in mechanisms of latent inhibition in rats.
    Loskutova LV; Luk'yanenko FYa ; Il'yuchenok RYu
    Neurosci Behav Physiol; 1990; 20(6):500-5. PubMed ID: 2096321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of the regulation of immunologic memory].
    Liashchenko KP
    Fiziol Zh (1978); 1988; 34(3):101-8. PubMed ID: 2900783
    [No Abstract]   [Full Text] [Related]  

  • 25. Sex differences in vasopressin and other neurotransmitter systems in the brain.
    De Vries GJ; Buijs RM; Van Leeuwen FW
    Prog Brain Res; 1984; 61():185-203. PubMed ID: 6152059
    [No Abstract]   [Full Text] [Related]  

  • 26. Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems.
    Westerink BH; Damsma G; Rollema H; De Vries JB; Horn AS
    Life Sci; 1987 Oct; 41(15):1763-76. PubMed ID: 2889121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin and peptide immunoneuromodulators: recent discoveries and new ideas.
    Silverman DH; Karnovsky ML
    Adv Enzymol Relat Areas Mol Biol; 1989; 62():203-26. PubMed ID: 2567107
    [No Abstract]   [Full Text] [Related]  

  • 28. [Research of interactions in the dopamine-serotonin-somatostatin system promises new outlook in fundamental and practical respects].
    Nikolaeva AA; Koroleva SV; Ashmarin IP
    Eksp Klin Farmakol; 2009; 72(2):60-4. PubMed ID: 19441733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glial heterogeneity and developing neurotransmitter systems.
    Lauder JM; Liu J
    Perspect Dev Neurobiol; 1994; 2(3):239-50. PubMed ID: 7850357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of acupuncture on central neurotransmitters].
    Xia Y; Cao XD
    Zhen Ci Yan Jiu; 1985; 10(2):81-91. PubMed ID: 2868813
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of precursors on brain neurotransmitter synthesis and brain functions.
    Fernstrom JD
    Diabetologia; 1981 Mar; 20 Suppl():281-9. PubMed ID: 6112187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Neuroendocrine-Immunological Interactions in Health and Disease.
    Pérez AR; Maya-Monteiro CM; Carvalho VF
    Front Endocrinol (Lausanne); 2021; 12():718893. PubMed ID: 34552560
    [No Abstract]   [Full Text] [Related]  

  • 33. Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
    Quik M; Sourkes TL
    J Neurochem; 1977 Jan; 28(1):137-47. PubMed ID: 13151
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular basis for the bidirectional modulation of the neuroendocrine and the immune systems.
    Cavagnaro J
    Year Immunol; 1986; 2():303-22. PubMed ID: 2883790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurohumoral mechanisms of the formation of antitumoral activity.
    Vinnitsky VB
    Ann N Y Acad Sci; 1988; 521():195-214. PubMed ID: 2897817
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of monoaminergic neurotransmitter systems in MDP-induced adjuvant effect.
    Strnadová V; Masek K
    Methods Find Exp Clin Pharmacol; 1991; 13(6):391-5. PubMed ID: 1679149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrastriatal transplants of embryonic dopaminergic neurons counteract the increase of striatal enkephalin immunostaining but not serotoninergic sprouting elicited by a neonatal lesion of the nigrostriatal dopaminergic pathway.
    Abrous DN; Manier M; Mennicken F; Feuerstein C; Le Moal M; Herman JP
    Eur J Neurosci; 1993 Feb; 5(2):128-36. PubMed ID: 7903185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of hypothalamic monoamines in the regulation of gonadotropin secretion].
    Adamskaia EI; Babichev VN
    Probl Endokrinol (Mosk); 1984; 30(1):36-42. PubMed ID: 6143314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The central nature of the interaction of neuromediator systems in immunomodulation].
    Al'perina EL; Idova GV
    Fiziol Zh SSSR Im I M Sechenova; 1990 Apr; 76(4):453-8. PubMed ID: 2170172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain.
    Vasar EE; Otter MYa ; Ryago LK
    Neurosci Behav Physiol; 1985; 15(3):232-6. PubMed ID: 2993947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.